Yidu Tech

Yidu Tech EBITDA Margin

The EBITDA Margin of Yidu Tech (2158.HK) as of Nov 4, 2026 is -11.42 %. In the previous year, EBITDA Margin was -13.32 % — a change of -14.26% (higher).

EBITDA Margin

-11.42 %

YoY

-14.26%

Last updated:

EBITDA Margin of Yidu Tech is 2026 -11.42 % . EBITDA Margin of Yidu Tech was 2025 -13.32 % . It decreases by -14.26% higher compared to the previous year.

The Yidu Tech EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2019
-404.84 CNY
Jan 1, 2020
-103.34 CNY
Jan 1, 2021
-50.13 CNY
Jan 1, 2022
-59.36 CNY
Jan 1, 2023
-72.32 CNY
Jan 1, 2024
-22.27 CNY
Jan 1, 2025
-13.32 CNY
Jan 1, 2026
-11.42 CNY
The Yidu Tech EBITDA Margin history
YEAREBITDA MarginYoY
-11.42 %-14.26%
-13.32 %-40.20%
-22.27 %-69.20%
-72.32 %+21.83%
-59.36 %+18.42%
-50.13 %-51.49%
-103.34 %-74.47%
-404.84 %-61.41%
-1,049.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yidu Tech Stock analysis

What does Yidu Tech do? Yidu Tech, Inc. generates revenue through three core business segments. The Big Data Platform and Solutions segment offers big data platform services and related solutions to customers. The Life Science Solutions segment provides analysis-driven clinical development, real-world evidence (RWE)-based research, and digital commercialization solutions to pharmaceutical, biotech, and medical device companies. The Health Management Platform and Solutions segment delivers research-driven personal health management platforms and insurance technology and disease management solutions to insurance companies and agencies. The company's primary data intelligence infrastructure, YiduCore, supports these offerings. The firm's customers include pharmaceutical, biotech, and medical device companies in the Life Science Solutions segment, while insurance companies and agencies are key clients for the Health Management Platform and Solutions segment. Big data platform services are sold to a broader customer base under the Big Data Platform and Solutions segment. YiduCore serves as the foundational infrastructure enabling the delivery of all data-driven solutions across the company's segments. Revenue streams are derived from data platform services, clinical development solutions, RWE-based research, digital commercialization, health management platforms, and insurance technology solutions. The company's business model leverages its YiduCore infrastructure to provide tailored data intelligence services to specialized industry segments, including life sciences and health management sectors. Yidu Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yidu Tech stock

EBITDA Margin of Yidu Tech is -11.42 % in 2026.

EBITDA Margin of Yidu Tech changed from -13.32 % to -11.42 %, representing a -14.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Yidu Tech since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Yidu Tech with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Yidu Tech

All Key Metrics — Yidu Tech